Lixia Yang

1.1k total citations
38 papers, 837 citations indexed

About

Lixia Yang is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Lixia Yang has authored 38 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Cancer Research and 13 papers in Immunology. Recurrent topics in Lixia Yang's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (9 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). Lixia Yang is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (9 papers) and Atherosclerosis and Cardiovascular Diseases (6 papers). Lixia Yang collaborates with scholars based in China, United States and United Kingdom. Lixia Yang's co-authors include Ruiwei Guo, Yan-Kun Shi, Guofu Zhu, Xing Liang, Feng Qi, Yang� Yang, Xianmei Wang, Nihong Lu, Hong Liu and Wenzhe Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Environmental Science & Technology and Oncogene.

In The Last Decade

Lixia Yang

37 papers receiving 830 citations

Peers

Lixia Yang
Comparison fields: 5 of 101
  • Molecular Biology 499
  • Cancer Research 375
  • Immunology 239
  • Epidemiology 72
  • Surgery 60
Replace Gemma Basatemur with:
Gemma Basatemur United Kingdom
Jun Shi China
Xinping Luo China
Dongmei Zhou China
Eithne Margaret Maguire United Kingdom
Jian Xiao China
Yan Han China
Vikash Reebye United Kingdom
Yuyang Liu China
Gemma Basatemur United Kingdom View profile →
Citations per field, relative to Lixia Yang
Lixia Yang · 1×
Citations per year, relative to Lixia Yang
Lixia Yang · 1×

Countries citing papers authored by Lixia Yang

Since Specialization
Citations

This map shows the geographic impact of Lixia Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lixia Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lixia Yang more than expected).

Fields of papers citing papers by Lixia Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lixia Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lixia Yang. The network helps show where Lixia Yang may publish in the future.

Co-authorship network of co-authors of Lixia Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Lixia Yang. A scholar is included among the top collaborators of Lixia Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lixia Yang. Lixia Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 0
2 1
3 8
4 2
5 7
6 1
7 9
8 106
9 6
10 24
11 19
12 12
13 10
14 50
15 87
16 12
17 7
18 49
19 5
20 18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026